Completed
Olaparib in Recurrent IDH-mutant Glioma
NCT03561870
- Conditions
- Disease Attributes, Glioma, Mutant High Grade Glioma, +11 more
- Locations
-
- Hospices Civils de Lyon Bron, France
Clinical trial condition
Explore clinical trials studying Recurrent IDH. Study availability and eligibility vary by location and protocol.
NCT03561870